Alpaca antibodiesABC OnlineThere are more than 130,000 alpacas in Australia, farmed for their wool and the protection of sheep herds mostly, but they may also hold the key to treating many serious infections. Therapeutic antibodies are molecules found …
|
FDA Nod for New Formulation of Teva’s Treanda – Analyst Blog
NASDAQ Treanda is used in indolent B-cell non-Hodgkin lymphoma patients whose disease has progressed during or within six months of treatment with Rituxan (rituximab) or a Rituxan-containing regimen, and in patients with chronic lymphocytic leukemia (CLL). |
New Findings in Anemia Described from Tampa General HospitalHispanicBusiness.comShe received traditional management with corticosteroids, intravenous immune globulin, rituximab, and partial splenic artery embolization. Despite these therapies, hemoglob…
New edition of classic manual provides insights into development and use of …EurekAlert (press release)The now classic lab manual Antibodies, by Harlow and Lane, has been revised, extended, and updated by Edward Greenfield of the Dana-Farber Cancer C…
NDA Filed for Idelalisib for Treating Non-Hodgkin LymphomaCancer NetworkThe study included 125 patients with indolent non-Hodgkin lymphoma, and all patients were refractory to rituximab and to alkylating-agent-containing chemotherapy regimens. The anal…
|
FDA Nod for New Formulation of Teva’s Treanda
Yahoo! News Treanda is used in indolent B-cell non-Hodgkin lymphoma patients whose disease has progressed during or within six months of treatment with Rituxan (rituximab) or a Rituxan-containing regimen, and in patients with chronic lymphocytic leukemia (:CLL). |
FDA Nod for New Formulation of Tevas TreandaZacks.comTreanda is used in indolent B-cell non-Hodgkin lymphoma patients whose disease has progressed during or within six months of treatment with Rituxan (rituximab) or a Rituxan-containing regimen, and in…
New Test Developed to Detect PED Virus AntibodiesThePigSite.comUS – Veterinary researchers at Iowa State University have developed a new test to detect antibodies against Porcine Epidemic Diarrhea Virus (PEDV), a costly disease in pigs confirmed in the…
Monthly Prescribing Reference |
New Treanda Formulation Approved
Monthly Prescribing Reference Treanda is an alkylating agent currently approved for use in chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin’s lymphoma (NHL) that has progressed during or within 6 months of treatment with rituximab or rituximab-containing regimen. |
|
FDA Approves Teva’s TREANDA® (bendamustine HCI) Injection, a New Liquid …
DailyFinance TREANDA is indicated for use in patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen, and in patients with chronic lymphocytic leukemia … |